EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lung Cancer Management: Revolutionizing Patient Outcomes Through Machine Learning and Artificial Intelligence

Taghi Riahi, Bahareh Shateri-Amiri, Amirhossein Hajialiasgary Najafabadi, Sina Garazhian iD, Hanieh Radkhah, Diar Zooravar iD, Sahar Mansouri, Roya Aghazadeh, Mohammadreza Bordbar, Shirin Raiszadeh

Cancer Reports · 2025

DOI: 10.1002/cnr2.70240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Taghi Riahi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Lung Neoplasms, Deep Learning, Machine Learning, Artificial Intelligence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Lung cancer remains a leading cause of cancer‐related deaths worldwide, with early detection critical for improving prognosis. Traditional machine learning (ML) models have shown limited generalizability in clinical settings. This study proposes a deep learning‐based approach using transfer learning to accurately segment lung tumor regions from CT scans and classify images as cancerous or noncancerous, aiming to overcome the limitations of conventional ML models.

Methods

We developed a two‐stage model utilizing a ResNet50 backbone within a U‐Net architecture for lesion segmentation, followed by a multi‐layer perceptron (MLP) for binary classification. The model was trained on publicly available CT scan datasets and evaluated on an independent clinical dataset from Hazrat Rasool Hospital, Iran. Training employed binary cross‐entropy and Dice loss functions. Data augmentation, dropout, and regularization were used to enhance model generalizability and prevent overfitting.

Results

The model achieved 94% accuracy on the real‐world clinical test set. Evaluation metrics, including F 1 score, Matthews correlation coefficient (MCC), Cohen's kappa, and Dice index, confirmed the model's robustness and diagnostic reliability. In comparison, traditional ML models performed poorly on external test data despite high training accuracy, highlighting a significant generalization gap.

Conclusion

This research presents a reliable deep learning framework for lung cancer detection that outperforms traditional ML approaches on external validation. The results demonstrate its potential for clinical deployment. Future work will focus on prospective validation, interpretability techniques, and integration into hospital workflows to support real‐time decision making and regulatory compliance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDeep LearningMachine LearningArtificial IntelligenceHumansTomography, X-Ray ComputedPrognosis

Stichwörter der Autor:innen

CT scanResNet50classification metricsdeep learninglung cancermachine learningtransfer learningtumor segmentation

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran.
  • Research Group Quantitative and Computational Biology, Max-Planck-Institute for Multidisciplinary Sciences, University of Göttingen, Göttingen, Germany.
  • Research Group of Quantitative and Systems Biology, Max-Planck-Institute for Multidisciplinary Sciences (MPI-NAT), University of Göttingen, Göttingen, Germany.
  • Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Sina Garazhian, Diar Zooravar

Zitieren

APA

Riahi, T., Shateri-Amiri, B., Najafabadi, A. H., Garazhian, S., Radkhah, H., Zooravar, D., Mansouri, S., Aghazadeh, R., Bordbar, M., & Raiszadeh, S. (2025). Lung Cancer Management: Revolutionizing Patient Outcomes Through Machine Learning and Artificial Intelligence. Cancer Reports. https://doi.org/10.1002/cnr2.70240

Vancouver

Riahi T, Shateri-Amiri B, Najafabadi AH, Garazhian S, Radkhah H, Zooravar D, et al. Lung Cancer Management: Revolutionizing Patient Outcomes Through Machine Learning and Artificial Intelligence. Cancer Reports. 2025. doi:10.1002/cnr2.70240

BibTeX
@article{Riahi2025,
  author = {Riahi, Taghi and Shateri-Amiri, Bahareh and Najafabadi, Amirhossein Hajialiasgary and Garazhian, Sina and Radkhah, Hanieh and Zooravar, Diar and Mansouri, Sahar and Aghazadeh, Roya and Bordbar, Mohammadreza and Raiszadeh, Shirin},
  title = {Lung Cancer Management: Revolutionizing Patient Outcomes Through Machine Learning and Artificial Intelligence},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70240}
}
Kostenlos starten →